Dexamethasone, rituximab, and cyclophosphamide as primary treatment of Waldenström macroglobulinemia: Final analysis of a phase 2 study

Citation:

Kastritis E, Gavriatopoulou M, Kyrtsonis M-C, Roussou M, Hadjiharissi E, Symeonidis A, Repoussis P, Michalis E, Delimpasi S, Tsatalas K, et al. Dexamethasone, rituximab, and cyclophosphamide as primary treatment of Waldenström macroglobulinemia: Final analysis of a phase 2 study. Blood [Internet]. 2015;126(11):1392 - 1394.

Notes:

Cited By :4Export Date: 21 February 2017

Website